Advanced

Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.

Ahmad Kiadaliri, Aliasghar LU ; Gerdtham, Ulf LU ; Eliasson, Bjorn and Steen Carlsson, Katarina LU (2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders 5(2). p.591-607
Abstract
This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c) ≤ 7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diabetes therapy : research, treatment and education of diabetes and related disorders
volume
5
issue
2
pages
591 - 607
publisher
Springer
external identifiers
  • pmid:25213800
  • scopus:84919617689
ISSN
1869-6953
DOI
10.1007/s13300-014-0080-0
language
English
LU publication?
yes
id
bfa68c70-de5f-4f5f-a765-7e7d34ec5ab2 (old id 4691822)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25213800?dopt=Abstract
date added to LUP
2014-10-05 20:01:32
date last changed
2017-10-01 04:08:56
@article{bfa68c70-de5f-4f5f-a765-7e7d34ec5ab2,
  abstract     = {This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c) ≤ 7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.},
  author       = {Ahmad Kiadaliri, Aliasghar and Gerdtham, Ulf and Eliasson, Bjorn and Steen Carlsson, Katarina},
  issn         = {1869-6953},
  language     = {eng},
  number       = {2},
  pages        = {591--607},
  publisher    = {Springer},
  series       = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
  title        = {Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.},
  url          = {http://dx.doi.org/10.1007/s13300-014-0080-0},
  volume       = {5},
  year         = {2014},
}